Global and Japan Active Pharma Ingredient Market Insights, Forecast to 2026

Global and Japan Active Pharma Ingredient Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Active Pharma Ingredient Product Introduction
1.2 Market Segments
1.3 Key Active Pharma Ingredient Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Active Pharma Ingredient Market Size Growth Rate by Type
1.4.2 Innovative Active Pharmaceutical Ingredients
1.4.3 Generic Active Pharmaceutical Ingredients
1.5 Market by Application
1.5.1 Global Active Pharma Ingredient Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Cardiovascular Disease
1.5.4 Diabetes
1.5.5 Central Nervous System and Neurological Disorders
1.5.6 Endocrinology
1.5.7 Other Therapeutic Applications
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Active Pharma Ingredient Market Size, Estimates and Forecasts
2.1.1 Global Active Pharma Ingredient Revenue 2015-2026
2.1.2 Global Active Pharma Ingredient Sales 2015-2026
2.2 Global Active Pharma Ingredient, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Active Pharma Ingredient Historical Market Size by Region (2015-2020)
2.3.1 Global Active Pharma Ingredient Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Active Pharma Ingredient Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Active Pharma Ingredient Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Active Pharma Ingredient Sales Forecast by Region (2021-2026)
2.4.2 Global Active Pharma Ingredient Revenue Forecast by Region (2021-2026)
3 Global Active Pharma Ingredient Competitor Landscape by Players
3.1 Global Top Active Pharma Ingredient Sales by Manufacturers
3.1.1 Global Active Pharma Ingredient Sales by Manufacturers (2015-2020)
3.1.2 Global Active Pharma Ingredient Sales Market Share by Manufacturers (2015-2020)
3.2 Global Active Pharma Ingredient Manufacturers by Revenue
3.2.1 Global Active Pharma Ingredient Revenue by Manufacturers (2015-2020)
3.2.2 Global Active Pharma Ingredient Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Active Pharma Ingredient Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Active Pharma Ingredient Revenue in 2019
3.2.5 Global Active Pharma Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Active Pharma Ingredient Price by Manufacturers
3.4 Global Active Pharma Ingredient Manufacturing Base Distribution, Product Types
3.4.1 Active Pharma Ingredient Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Active Pharma Ingredient Product Type
3.4.3 Date of International Manufacturers Enter into Active Pharma Ingredient Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Active Pharma Ingredient Market Size by Type (2015-2020)
4.1.1 Global Active Pharma Ingredient Sales by Type (2015-2020)
4.1.2 Global Active Pharma Ingredient Revenue by Type (2015-2020)
4.1.3 Active Pharma Ingredient Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Active Pharma Ingredient Market Size Forecast by Type (2021-2026)
4.2.1 Global Active Pharma Ingredient Sales Forecast by Type (2021-2026)
4.2.2 Global Active Pharma Ingredient Revenue Forecast by Type (2021-2026)
4.2.3 Active Pharma Ingredient Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Active Pharma Ingredient Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Active Pharma Ingredient Market Size by Application (2015-2020)
5.1.1 Global Active Pharma Ingredient Sales by Application (2015-2020)
5.1.2 Global Active Pharma Ingredient Revenue by Application (2015-2020)
5.1.3 Active Pharma Ingredient Price by Application (2015-2020)
5.2 Active Pharma Ingredient Market Size Forecast by Application (2021-2026)
5.2.1 Global Active Pharma Ingredient Sales Forecast by Application (2021-2026)
5.2.2 Global Active Pharma Ingredient Revenue Forecast by Application (2021-2026)
5.2.3 Global Active Pharma Ingredient Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Active Pharma Ingredient Market Size YoY Growth 2015-2026
6.1.1 Japan Active Pharma Ingredient Sales YoY Growth 2015-2026
6.1.2 Japan Active Pharma Ingredient Revenue YoY Growth 2015-2026
6.1.3 Japan Active Pharma Ingredient Market Share in Global Market 2015-2026
6.2 Japan Active Pharma Ingredient Market Size by Players (International and Local Players)
6.2.1 Japan Top Active Pharma Ingredient Players by Sales (2015-2020)
6.2.2 Japan Top Active Pharma Ingredient Players by Revenue (2015-2020)
6.3 Japan Active Pharma Ingredient Historic Market Review by Type (2015-2020)
6.3.1 Japan Active Pharma Ingredient Sales Market Share by Type (2015-2020)
6.3.2 Japan Active Pharma Ingredient Revenue Market Share by Type (2015-2020)
6.3.3 Japan Active Pharma Ingredient Price by Type (2015-2020)
6.4 Japan Active Pharma Ingredient Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Active Pharma Ingredient Sales Forecast by Type (2021-2026)
6.4.2 Japan Active Pharma Ingredient Revenue Forecast by Type (2021-2026)
6.4.3 Japan Active Pharma Ingredient Price Forecast by Type (2021-2026)
6.5 Japan Active Pharma Ingredient Historic Market Review by Application (2015-2020)
6.5.1 Japan Active Pharma Ingredient Sales Market Share by Application (2015-2020)
6.5.2 Japan Active Pharma Ingredient Revenue Market Share by Application (2015-2020)
6.5.3 Japan Active Pharma Ingredient Price by Application (2015-2020)
6.6 Japan Active Pharma Ingredient Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Active Pharma Ingredient Sales Forecast by Application (2021-2026)
6.6.2 Japan Active Pharma Ingredient Revenue Forecast by Application (2021-2026)
6.6.3 Japan Active Pharma Ingredient Price Forecast by Application (2021-2026)
7 North America
7.1 North America Active Pharma Ingredient Market Size YoY Growth 2015-2026
7.2 North America Active Pharma Ingredient Market Facts & Figures by Country
7.2.1 North America Active Pharma Ingredient Sales by Country (2015-2020)
7.2.2 North America Active Pharma Ingredient Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Active Pharma Ingredient Market Size YoY Growth 2015-2026
8.2 Europe Active Pharma Ingredient Market Facts & Figures by Country
8.2.1 Europe Active Pharma Ingredient Sales by Country
8.2.2 Europe Active Pharma Ingredient Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Active Pharma Ingredient Market Size YoY Growth 2015-2026
9.2 Asia Pacific Active Pharma Ingredient Market Facts & Figures by Country
9.2.1 Asia Pacific Active Pharma Ingredient Sales by Region (2015-2020)
9.2.2 Asia Pacific Active Pharma Ingredient Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Active Pharma Ingredient Market Size YoY Growth 2015-2026
10.2 Latin America Active Pharma Ingredient Market Facts & Figures by Country
10.2.1 Latin America Active Pharma Ingredient Sales by Country
10.2.2 Latin America Active Pharma Ingredient Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Active Pharma Ingredient Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Active Pharma Ingredient Market Facts & Figures by Country
11.2.1 Middle East and Africa Active Pharma Ingredient Sales by Country
11.2.2 Middle East and Africa Active Pharma Ingredient Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Description and Business Overview
12.1.3 Teva Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Teva Active Pharma Ingredient Products Offered
12.1.5 Teva Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Description and Business Overview
12.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis Active Pharma Ingredient Products Offered
12.2.5 Novartis Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Description and Business Overview
12.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Active Pharma Ingredient Products Offered
12.3.5 Pfizer Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Corporation Information
12.4.2 Johnson & Johnson Description and Business Overview
12.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Johnson & Johnson Active Pharma Ingredient Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Mylan
12.5.1 Mylan Corporation Information
12.5.2 Mylan Description and Business Overview
12.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Mylan Active Pharma Ingredient Products Offered
12.5.5 Mylan Recent Development
12.6 North China Pharmaceutical Group
12.6.1 North China Pharmaceutical Group Corporation Information
12.6.2 North China Pharmaceutical Group Description and Business Overview
12.6.3 North China Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
12.6.4 North China Pharmaceutical Group Active Pharma Ingredient Products Offered
12.6.5 North China Pharmaceutical Group Recent Development
12.7 Dr. Reddy's Laboratories
12.7.1 Dr. Reddy's Laboratories Corporation Information
12.7.2 Dr. Reddy's Laboratories Description and Business Overview
12.7.3 Dr. Reddy's Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Dr. Reddy's Laboratories Active Pharma Ingredient Products Offered
12.7.5 Dr. Reddy's Laboratories Recent Development
12.8 Roche
12.8.1 Roche Corporation Information
12.8.2 Roche Description and Business Overview
12.8.3 Roche Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Roche Active Pharma Ingredient Products Offered
12.8.5 Roche Recent Development
12.9 Aurobindo pharma
12.9.1 Aurobindo pharma Corporation Information
12.9.2 Aurobindo pharma Description and Business Overview
12.9.3 Aurobindo pharma Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Aurobindo pharma Active Pharma Ingredient Products Offered
12.9.5 Aurobindo pharma Recent Development
12.10 Sun Pharmaceutical Industries
12.10.1 Sun Pharmaceutical Industries Corporation Information
12.10.2 Sun Pharmaceutical Industries Description and Business Overview
12.10.3 Sun Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Sun Pharmaceutical Industries Active Pharma Ingredient Products Offered
12.10.5 Sun Pharmaceutical Industries Recent Development
12.11 Teva
12.11.1 Teva Corporation Information
12.11.2 Teva Description and Business Overview
12.11.3 Teva Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Teva Active Pharma Ingredient Products Offered
12.11.5 Teva Recent Development
12.12 Bayer
12.12.1 Bayer Corporation Information
12.12.2 Bayer Description and Business Overview
12.12.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Bayer Products Offered
12.12.5 Bayer Recent Development
12.13 BASF
12.13.1 BASF Corporation Information
12.13.2 BASF Description and Business Overview
12.13.3 BASF Sales, Revenue and Gross Margin (2015-2020)
12.13.4 BASF Products Offered
12.13.5 BASF Recent Development
12.14 DSM
12.14.1 DSM Corporation Information
12.14.2 DSM Description and Business Overview
12.14.3 DSM Sales, Revenue and Gross Margin (2015-2020)
12.14.4 DSM Products Offered
12.14.5 DSM Recent Development
12.15 Zhejiang Medicine
12.15.1 Zhejiang Medicine Corporation Information
12.15.2 Zhejiang Medicine Description and Business Overview
12.15.3 Zhejiang Medicine Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Zhejiang Medicine Products Offered
12.15.5 Zhejiang Medicine Recent Development
12.16 Biocon
12.16.1 Biocon Corporation Information
12.16.2 Biocon Description and Business Overview
12.16.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Biocon Products Offered
12.16.5 Biocon Recent Development
12.17 Johnson Matthey
12.17.1 Johnson Matthey Corporation Information
12.17.2 Johnson Matthey Description and Business Overview
12.17.3 Johnson Matthey Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Johnson Matthey Products Offered
12.17.5 Johnson Matthey Recent Development
12.18 Hisun Pharmacy
12.18.1 Hisun Pharmacy Corporation Information
12.18.2 Hisun Pharmacy Description and Business Overview
12.18.3 Hisun Pharmacy Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Hisun Pharmacy Products Offered
12.18.5 Hisun Pharmacy Recent Development
12.19 Cambrex
12.19.1 Cambrex Corporation Information
12.19.2 Cambrex Description and Business Overview
12.19.3 Cambrex Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Cambrex Products Offered
12.19.5 Cambrex Recent Development
12.20 Shandong Xinhua Pharmaceutical
12.20.1 Shandong Xinhua Pharmaceutical Corporation Information
12.20.2 Shandong Xinhua Pharmaceutical Description and Business Overview
12.20.3 Shandong Xinhua Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Shandong Xinhua Pharmaceutical Products Offered
12.20.5 Shandong Xinhua Pharmaceutical Recent Development
12.21 Lonza group
12.21.1 Lonza group Corporation Information
12.21.2 Lonza group Description and Business Overview
12.21.3 Lonza group Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Lonza group Products Offered
12.21.5 Lonza group Recent Development
12.22 Huahai Pharmaceutical
12.22.1 Huahai Pharmaceutical Corporation Information
12.22.2 Huahai Pharmaceutical Description and Business Overview
12.22.3 Huahai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Huahai Pharmaceutical Products Offered
12.22.5 Huahai Pharmaceutical Recent Development
12.23 Haerbin Pharmaceutical Group
12.23.1 Haerbin Pharmaceutical Group Corporation Information
12.23.2 Haerbin Pharmaceutical Group Description and Business Overview
12.23.3 Haerbin Pharmaceutical Group Sales, Revenue and Gross Margin (2015-2020)
12.23.4 Haerbin Pharmaceutical Group Products Offered
12.23.5 Haerbin Pharmaceutical Group Recent Development
12.24 Cipla
12.24.1 Cipla Corporation Information
12.24.2 Cipla Description and Business Overview
12.24.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
12.24.4 Cipla Products Offered
12.24.5 Cipla Recent Development
12.25 Tian Yao
12.25.1 Tian Yao Corporation Information
12.25.2 Tian Yao Description and Business Overview
12.25.3 Tian Yao Sales, Revenue and Gross Margin (2015-2020)
12.25.4 Tian Yao Products Offered
12.25.5 Tian Yao Recent Development
12.26 Lupin
12.26.1 Lupin Corporation Information
12.26.2 Lupin Description and Business Overview
12.26.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
12.26.4 Lupin Products Offered
12.26.5 Lupin Recent Development
12.27 North East Pharmaceutical
12.27.1 North East Pharmaceutical Corporation Information
12.27.2 North East Pharmaceutical Description and Business Overview
12.27.3 North East Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.27.4 North East Pharmaceutical Products Offered
12.27.5 North East Pharmaceutical Recent Development
12.28 Albemarle
12.28.1 Albemarle Corporation Information
12.28.2 Albemarle Description and Business Overview
12.28.3 Albemarle Sales, Revenue and Gross Margin (2015-2020)
12.28.4 Albemarle Products Offered
12.28.5 Albemarle Recent Development
12.29 Shandong Lukang Pharmaceutical
12.29.1 Shandong Lukang Pharmaceutical Corporation Information
12.29.2 Shandong Lukang Pharmaceutical Description and Business Overview
12.29.3 Shandong Lukang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.29.4 Shandong Lukang Pharmaceutical Products Offered
12.29.5 Shandong Lukang Pharmaceutical Recent Development
12.30 Jiangsu Hengrui Medicine
12.30.1 Jiangsu Hengrui Medicine Corporation Information
12.30.2 Jiangsu Hengrui Medicine Description and Business Overview
12.30.3 Jiangsu Hengrui Medicine Sales, Revenue and Gross Margin (2015-2020)
12.30.4 Jiangsu Hengrui Medicine Products Offered
12.30.5 Jiangsu Hengrui Medicine Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Active Pharma Ingredient Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Active Pharma Ingredient Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Active Pharma Ingredient Market Segments
Table 2. Ranking of Global Top Active Pharma Ingredient Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Active Pharma Ingredient Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Innovative Active Pharmaceutical Ingredients
Table 5. Major Manufacturers of Generic Active Pharmaceutical Ingredients
Table 6. Global Active Pharma Ingredient Market Size Growth Rate by Application 2020-2026 (MT)
Table 7. Global Active Pharma Ingredient Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 8. Global Active Pharma Ingredient Sales by Regions 2015-2020 (MT)
Table 9. Global Active Pharma Ingredient Sales Market Share by Regions (2015-2020)
Table 10. Global Active Pharma Ingredient Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Active Pharma Ingredient Sales Forecast by Region (2021-2026) (MT)
Table 12. Global Active Pharma Ingredient Sales by Manufacturers (2015-2020) (MT)
Table 13. Global Active Pharma Ingredient Sales Share by Manufacturers (2015-2020)
Table 14. Global Active Pharma Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Active Pharma Ingredient by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Pharma Ingredient as of 2019)
Table 16. Active Pharma Ingredient Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Active Pharma Ingredient Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Active Pharma Ingredient Price (2015-2020) (USD/MT)
Table 19. Active Pharma Ingredient Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Active Pharma Ingredient Product Type
Table 21. Date of International Manufacturers Enter into Active Pharma Ingredient Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Active Pharma Ingredient Sales by Type (2015-2020) (MT)
Table 24. Global Active Pharma Ingredient Sales Share by Type (2015-2020)
Table 25. Global Active Pharma Ingredient Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Active Pharma Ingredient Revenue Share by Type (2015-2020)
Table 27. Active Pharma Ingredient Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Active Pharma Ingredient Sales Share by Type (2021-2026)
Table 29. Global Active Pharma Ingredient Sales by Application (2015-2020) (MT)
Table 30. Global Active Pharma Ingredient Sales Share by Application (2015-2020)
Table 31. Global Active Pharma Ingredient Sales Share by Application (2021-2026)
Table 32. Global Active Pharma Ingredient Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Active Pharma Ingredient Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Active Pharma Ingredient Revenue Market Share Forecast by Application (2021-2026)
Table 35. Japan Active Pharma Ingredient Sales (MT) of Key Companies (2015-2020)
Table 36. Japan Active Pharma Ingredient Sales Share by Company (2015-2020)
Table 37. Japan Active Pharma Ingredient Revenue (US$ Million) by Company (2015-2020)
Table 38. Japan Active Pharma Ingredient Sales (MT) by Type (2015-2020)
Table 39. Japan Active Pharma Ingredient Sales Share by Type (2015-2020)
Table 40. Japan Active Pharma Ingredient Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. Japan Active Pharma Ingredient Price (MT) by Type (2015-2020)
Table 42. Japan Active Pharma Ingredient Sales (MT) by Type (2021-2026)
Table 43. Japan Active Pharma Ingredient Sales Share by Type (2021-2026)
Table 44. Japan Active Pharma Ingredient Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. Japan Active Pharma Ingredient Revenue Share by Type (2021-2026)
Table 46. Japan Active Pharma Ingredient Price (MT) by Type (2021-2026)
Table 47. Japan Active Pharma Ingredient Sales (MT) by Application (2015-2020)
Table 48. Japan Active Pharma Ingredient Sales Share by Application (2015-2020)
Table 49. Japan Active Pharma Ingredient Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. Japan Active Pharma Ingredient Sales (MT) by Application (2021-2026)
Table 51. Japan Active Pharma Ingredient Sales Share by Application (2021-2026)
Table 52. Japan Active Pharma Ingredient Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. Japan Active Pharma Ingredient Revenue Share by Application (2021-2026)
Table 54. North America Active Pharma Ingredient Sales by Country (2015-2020) (MT)
Table 55. North America Active Pharma Ingredient Sales Market Share by Country (2015-2020)
Table 56. North America Active Pharma Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Active Pharma Ingredient Revenue Market Share by Country (2015-2020)
Table 58. Europe Active Pharma Ingredient Sales by Country (2015-2020) (MT)
Table 59. Europe Active Pharma Ingredient Sales Market Share by Country (2015-2020)
Table 60. Europe Active Pharma Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Active Pharma Ingredient Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Active Pharma Ingredient Sales by Region (2015-2020) (MT)
Table 63. Asia Pacific Active Pharma Ingredient Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Active Pharma Ingredient Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Active Pharma Ingredient Revenue Market Share by Region (2015-2020)
Table 66. Latin America Active Pharma Ingredient Sales by Country (2015-2020) (MT)
Table 67. Latin America Active Pharma Ingredient Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Active Pharma Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Active Pharma Ingredient Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Active Pharma Ingredient Sales by Country (2015-2020) (MT)
Table 71. Middle East and Africa Active Pharma Ingredient Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Active Pharma Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Active Pharma Ingredient Revenue Market Share by Country (2015-2020)
Table 74. Teva Corporation Information
Table 75. Teva Description and Business Overview
Table 76. Teva Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Teva Active Pharma Ingredient Product
Table 78. Teva Recent Development
Table 79. Novartis Corporation Information
Table 80. Novartis Description and Business Overview
Table 81. Novartis Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Novartis Product
Table 83. Novartis Recent Development
Table 84. Pfizer Corporation Information
Table 85. Pfizer Description and Business Overview
Table 86. Pfizer Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Pfizer Product
Table 88. Pfizer Recent Development
Table 89. Johnson & Johnson Corporation Information
Table 90. Johnson & Johnson Description and Business Overview
Table 91. Johnson & Johnson Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Johnson & Johnson Product
Table 93. Johnson & Johnson Recent Development
Table 94. Mylan Corporation Information
Table 95. Mylan Description and Business Overview
Table 96. Mylan Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Mylan Product
Table 98. Mylan Recent Development
Table 99. North China Pharmaceutical Group Corporation Information
Table 100. North China Pharmaceutical Group Description and Business Overview
Table 101. North China Pharmaceutical Group Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. North China Pharmaceutical Group Product
Table 103. North China Pharmaceutical Group Recent Development
Table 104. Dr. Reddy's Laboratories Corporation Information
Table 105. Dr. Reddy's Laboratories Description and Business Overview
Table 106. Dr. Reddy's Laboratories Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Dr. Reddy's Laboratories Product
Table 108. Dr. Reddy's Laboratories Recent Development
Table 109. Roche Corporation Information
Table 110. Roche Description and Business Overview
Table 111. Roche Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Roche Product
Table 113. Roche Recent Development
Table 114. Aurobindo pharma Corporation Information
Table 115. Aurobindo pharma Description and Business Overview
Table 116. Aurobindo pharma Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Aurobindo pharma Product
Table 118. Aurobindo pharma Recent Development
Table 119. Sun Pharmaceutical Industries Corporation Information
Table 120. Sun Pharmaceutical Industries Description and Business Overview
Table 121. Sun Pharmaceutical Industries Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Sun Pharmaceutical Industries Product
Table 123. Sun Pharmaceutical Industries Recent Development
Table 124. Boehringer Ingelheim GmbH Corporation Information
Table 125. Boehringer Ingelheim GmbH Description and Business Overview
Table 126. Boehringer Ingelheim GmbH Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. Boehringer Ingelheim GmbH Product
Table 128. Boehringer Ingelheim GmbH Recent Development
Table 129. Bayer Corporation Information
Table 130. Bayer Description and Business Overview
Table 131. Bayer Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Bayer Product
Table 133. Bayer Recent Development
Table 134. BASF Corporation Information
Table 135. BASF Description and Business Overview
Table 136. BASF Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. BASF Product
Table 138. BASF Recent Development
Table 139. DSM Corporation Information
Table 140. DSM Description and Business Overview
Table 141. DSM Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. DSM Product
Table 143. DSM Recent Development
Table 144. Zhejiang Medicine Corporation Information
Table 145. Zhejiang Medicine Description and Business Overview
Table 146. Zhejiang Medicine Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 147. Zhejiang Medicine Product
Table 148. Zhejiang Medicine Recent Development
Table 149. Biocon Corporation Information
Table 150. Biocon Description and Business Overview
Table 151. Biocon Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 152. Biocon Product
Table 153. Biocon Recent Development
Table 154. Johnson Matthey Corporation Information
Table 155. Johnson Matthey Description and Business Overview
Table 156. Johnson Matthey Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 157. Johnson Matthey Product
Table 158. Johnson Matthey Recent Development
Table 159. Hisun Pharmacy Corporation Information
Table 160. Hisun Pharmacy Description and Business Overview
Table 161. Hisun Pharmacy Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 162. Hisun Pharmacy Product
Table 163. Hisun Pharmacy Recent Development
Table 164. Cambrex Corporation Information
Table 165. Cambrex Description and Business Overview
Table 166. Cambrex Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 167. Cambrex Product
Table 168. Cambrex Recent Development
Table 169. Shandong Xinhua Pharmaceutical Corporation Information
Table 170. Shandong Xinhua Pharmaceutical Description and Business Overview
Table 171. Shandong Xinhua Pharmaceutical Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 172. Shandong Xinhua Pharmaceutical Product
Table 173. Shandong Xinhua Pharmaceutical Recent Development
Table 174. Lonza group Corporation Information
Table 175. Lonza group Description and Business Overview
Table 176. Lonza group Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 177. Lonza group Product
Table 178. Lonza group Recent Development
Table 179. Huahai Pharmaceutical Corporation Information
Table 180. Huahai Pharmaceutical Description and Business Overview
Table 181. Huahai Pharmaceutical Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 182. Huahai Pharmaceutical Product
Table 183. Huahai Pharmaceutical Recent Development
Table 184. Haerbin Pharmaceutical Group Corporation Information
Table 185. Haerbin Pharmaceutical Group Description and Business Overview
Table 186. Haerbin Pharmaceutical Group Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 187. Haerbin Pharmaceutical Group Product
Table 188. Haerbin Pharmaceutical Group Recent Development
Table 189. Cipla Corporation Information
Table 190. Cipla Description and Business Overview
Table 191. Cipla Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 192. Cipla Product
Table 193. Cipla Recent Development
Table 194. Tian Yao Corporation Information
Table 195. Tian Yao Description and Business Overview
Table 196. Tian Yao Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 197. Tian Yao Product
Table 198. Tian Yao Recent Development
Table 199. Lupin Corporation Information
Table 200. Lupin Description and Business Overview
Table 201. Lupin Active Pharma Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 202. Lupin Product
Table 203. Lupin Recent Development
Table 204. North East Pharmaceutical Corporation Information

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs